Accuri Cytometers nearly doubles staff, takes in $4 million more in VC

Thursday, July 16, 2009 | Source: Concentrate
More and more venture capital investment is flooding Ann Arbor-based start-ups these days.

Excerpt:

Ann Arbor's Accuri Cytometers continues to blaze big trails towards rapid growth, bringing in millions in financing and creating dozens of new jobs.

The Ann Arbor-based firm nailed down $4 million in Series D financing (think venture capital funding) from the likes of Fidelity Biosciences, Flagship Ventures, Baird Venture Partners, Arboretum Ventures and InvestMichigan! The money is expected to help push forward the commercialization of its Accuri C6 Flow Cytometer System and open up markets in Europe and elsewhere around the world.  

"This is expected to take us through to profitability," says Jen Baird, CEO of Accuri Cytometers.

Read the rest of the story here.
Enjoy this story? Sign up for free solutions-based reporting in your inbox each week.

Related Tags

Biotechnology, Higher Education, Investment, The University Of Michigan, Venture Capital 

Recommended Content

Related Company

  • Accuri Cytometers
    173 Parkland Plaza
    Ann Arbor, MI 48103 Website
    You may not know what a cytometer does, but here's what it means for Ann Arbor-based Accuri: jobs, growth, and expansion.
Sponsored By
Regions
Focus Areas
Copyright © Issue Media Group. All rights reserved.